Financial Performance - The company's operating revenue for 2018 was CNY 1,063,357,911, representing a decrease of 12.70% compared to CNY 1,217,589,896 in 2017[17]. - The net profit attributable to shareholders was a loss of CNY 782,170,138.5, a significant decline of 1,255.21% from a profit of CNY 67,995,067.28 in the previous year[17]. - The basic earnings per share for 2018 was -CNY 0.99, a decrease of 1,200.00% compared to CNY 0.08 in 2017[17]. - The total profit for the year was CNY -772,294,877.87, a year-on-year decrease of 1,046.83%[38]. - The total operating revenue for the year was CNY 1,063,357,911.35, a year-on-year decrease of 12.70%[38]. - The net profit attributable to shareholders of the listed company was CNY -782,170,138.54, a year-on-year decrease of 1,255.21%[38]. - The total profit was CNY -772,294,877.87, representing a year-on-year decline of 1,046.83%[47]. - The company reported a significant decrease in investment amount, with a current period investment of ¥7,000,000.00, down 97.31% from the previous year's ¥260,422,692.00[75]. - The company experienced a net loss of CNY 12,413,473.39 in 2018, indicating ongoing financial challenges[96]. Assets and Liabilities - The total assets at the end of 2018 were CNY 2,018,655,562, down 32.48% from CNY 3,069,523,158 at the end of 2017[17]. - The net assets attributable to shareholders decreased by 32.60% to CNY 1,586,313,290 from CNY 2,436,168,897 in 2017[17]. - The company reported total assets of CNY 16,200,366.98 and a net asset of -CNY 3,770,592.27 as of December 31, 2018[96]. - The company’s cash and cash equivalents decreased by ¥145,395,119.59, a 277.81% increase in net decrease compared to the previous year[67]. - The proportion of inventory in total assets increased by 2.97% to 12.57%[71]. Cash Flow - The net cash flow from operating activities was CNY -86,377,856.21, a decline of 109.55% compared to CNY 5,556,981.71 in 2017[17]. - The net cash flow from operating activities was CNY 62,267,933.30 in Q4, showing a recovery from previous quarters[1]. - Operating cash inflow for 2018 was ¥1,200,985,450.66, reflecting a year-on-year increase of 3.21%[67]. - The net cash flow from operating activities was ¥5,556,981.71, a significant improvement from a net outflow of ¥72,810,344.44 in the previous year[67]. Dividends and Shareholder Returns - The company plans not to distribute cash dividends or issue bonus shares for the year[6]. - The company proposed no cash dividends for the 2018 fiscal year, marking a change from previous years where cash dividends were distributed[114]. - The total cash dividends for 2018 were reported as RMB 0.00, indicating no distribution[115]. Subsidiary Performance - The subsidiary Ruiyu Fitness achieved operating revenue of CNY 209,641,123.77 and net profit of CNY 23,229,734.48 during the reporting period[48]. - The subsidiary Jiugong Jianye reported steady growth with operating revenue of CNY 363,596,414.90 and net profit of CNY 39,626,426.74[49]. - Anhui Jiugong Health achieved a total revenue of CNY 215,235,789, but reported a net loss of CNY -66,687,731[90]. - Shanghai Ruiyu Fitness generated revenue of CNY 209,641,123 with a net profit of CNY 23,229,734, reflecting a strong performance in the fitness and leisure sector[90]. - Shenzhen Furuisi Health reported total assets of CNY 257,221,825 and a net profit of CNY 39,626,426, indicating robust growth in the massage equipment market[95]. Strategic Initiatives - The company plans to enhance its product line and marketing chain through mergers and acquisitions, focusing on high-tech talent and sustainable industries[26]. - The company has developed a comprehensive health service platform covering various health management services, enhancing its competitive edge[43]. - The company is focusing on improving operational efficiency and reducing costs through industry integration and management optimization[43]. - The company plans to enhance internal management and optimize its product and industry structure through technological innovation and management reform in 2019[100]. - The company aims to strengthen brand building and optimize existing sales channels to improve operational efficiency and reduce costs[98]. Risks and Compliance - The company has outlined potential risks and corresponding countermeasures in its future development outlook section[5]. - The company has identified market risks due to economic fluctuations and increasing competition, prompting adjustments in marketing strategies[103]. - The company has recognized goodwill impairment risks associated with acquisitions, particularly for the acquisitions of Jiugong Jianye and Ruiyu Fitness[104]. - The company is at risk of penalties due to potential non-compliance with employee social security and housing fund contributions[148]. Governance and Management - The company has committed to maintaining independent financial management and governance structures[116]. - The actual controller and related parties have fulfilled their commitments regarding the independence of the company's operations[116]. - The company has established a complete and independent labor and compensation management system[118]. - The company guarantees that all assets are under its control and will not be misappropriated by related parties[118]. Research and Development - Research and development expenses for 2018 were ¥63,711,806.90, an increase of 20.93% compared to the previous year, and represented 5.99% of total revenue[64]. - The company will increase investment in research and development to enhance product quality and technical competitiveness[102]. - The company has established a stable R&D team to support ongoing and future projects[144]. Share Structure and Transactions - The total number of shares before the change was 804,542,300, with 30.01% being restricted shares and 69.99% being unrestricted shares[186]. - The number of restricted shares decreased by 48,796,400, resulting in a new total of 192,671,500 restricted shares, which is 23.95% of the total[186]. - The company released a total of 10,749,854 shares from restrictions during the reporting period, including 8,559,697 shares from Gong Xiangmin and 2,190,157 shares from Chen Mengyang[187]. - The company’s stock incentive plan allows for 25% of the total shares held by directors and senior management to be released from restrictions annually[187]. Legal and Regulatory Matters - There were no major lawsuits or arbitration matters reported during the year[160]. - The company has not faced any penalties or rectification issues during the reporting period[161]. - The board has approved corrections to accounting errors to enhance the accuracy of financial reporting[155].

Financial Performance - The company's operating revenue for 2018 was ¥1,063,357,911, a decrease of 12.70% compared to ¥1,217,589,896 in 2017[16] - The net profit attributable to shareholders was -¥782,170,138.5, representing a decline of 1,255.21% from a profit of ¥67,995,067.28 in the previous year[16] - The basic earnings per share for 2018 was -¥0.99, a decrease of 1,200.00% compared to ¥0.08 in 2017[16] - The total profit for the year was CNY -772,294,877.87, a decrease of 1,046.83% year-on-year[36] - The total operating revenue for the year was CNY 1,063,357,911.35, a decrease of 12.70% year-on-year[36] - The net profit attributable to shareholders of the listed company was CNY -782,170,138.54, a decline of 1,255.21% year-on-year[36] - The gross profit margin for the massage product series was 22.35%, down from the previous year, reflecting a decrease of 5.84%[55] Assets and Liabilities - The total assets at the end of 2018 were ¥2,018,655,562, down 32.48% from ¥3,069,523,158 at the end of 2017[16] - The net assets attributable to shareholders decreased by 32.60% to ¥1,586,313,290 from ¥2,436,168,897 in 2017[16] - The company's total assets included cash and cash equivalents of ¥179,627,750.60, which represented 8.90% of total assets[69] - The long-term equity investments increased to ¥228,630,160.00, accounting for 11.33% of total assets, up from 7.10% the previous year[69] Cash Flow - The net cash flow from operating activities was -¥86,377,856.21, a decline of 109.55% compared to ¥5,556,981.71 in 2017[16] - The net cash flow from operating activities was CNY 62,267,933.30 in Q4, following a negative cash flow in the previous three quarters[1] - Operating cash inflow totaled ¥1,200,985,450.66, reflecting a year-on-year increase of 3.21%[64] - The net cash flow from operating activities was ¥5,556,981.71, a significant improvement from a net outflow of ¥72,810,344.44 in the previous year[65] Investment and Development - The company is focusing on expanding its product line and enhancing its technological capabilities through acquisitions and investments in high-tech talent[25] - The company has developed a comprehensive health service platform covering various health-related products and services, enhancing its market competitiveness[41] - The company has established a "super donor" iPSC cell resource bank, which can serve approximately 36 million people in China, addressing challenges in cell medical applications[48] - The company increased its construction projects by 100%, primarily due to the establishment of a new production and R&D center and the Wuhu production base[40] Market Strategy - The company operates under different business models for domestic and international markets, including direct sales and ODM for overseas clients[35] - The company has established a multi-channel marketing strategy combining distribution, direct sales, e-commerce, and experience stores in the domestic market[35] - The company aims to strengthen its core competitiveness and ensure sustainable development in the health industry[25] - The company faces market risks due to complex economic conditions and increasing competition, prompting adjustments in market strategies and marketing models[102] Shareholder and Dividend Policy - The company plans not to distribute cash dividends or issue bonus shares[5] - The company proposed a profit distribution plan for 2018 that includes no cash dividends, no stock bonuses, and no capital reserve transfers[113] - The total cash dividend amount for 2018 was RMB 0.00, with a total distributable profit also at RMB 0.00[114] - The company has maintained a consistent cash dividend policy over the past three years, with no changes or adjustments made in 2018[113] Risk Management - The company has identified potential risks in its future development and outlined corresponding countermeasures[4] - The company has recognized significant goodwill from acquisitions, with risks of impairment due to potential underperformance of acquired entities[103] - The company plans to implement a robust management strategy to address risks associated with its expanding scale and ensure effective internal controls[105] Compliance and Governance - The company has not reported any significant discrepancies between financial data disclosed under different accounting standards[19] - The company has undergone adjustments in accounting policies and corrections of accounting errors during the reporting period[17] - The company has not encountered any major changes in the feasibility of the projects funded by raised capital[84] - The company has made commitments to avoid conflicts of interest in related party transactions, ensuring fair and reasonable dealings[152] Subsidiaries and Performance - The company’s subsidiary, Ruiyu Fitness, reported operating revenue of CNY 209,641,123.77 and net profit of CNY 23,229,734.48 during the reporting period[46] - The subsidiary, Jiugong Jianye, achieved operating revenue of CNY 363,596,414.90 and net profit of CNY 39,626,426.74, despite facing challenges in shared massage chair sales[47] - Anhui Jiugong Health Industry Co., Ltd. reported a total revenue of CNY 215,235,789 with a net loss of CNY -66,687,731 for the reporting period[88] Share Structure and Ownership - The total number of shares outstanding is 241,467,987, with 49,188,207 shares held under lock-up agreements[191] - The largest shareholder, Jin Daoming, holds 10.83% of the shares, totaling 87,138,800 shares, with a decrease of 2,904,000 shares during the reporting period[193] - The company has a total of 50,046 shareholders at the end of the reporting period, an increase from 47,406 at the end of the previous month[193] - The controlling shareholder changed to Rongjie Investment Holding Group Co., Ltd. on August 29, 2018[198]

Financial Performance - Total revenue for Q1 2019 was ¥183,438,190.21, a decrease of 29.91% compared to ¥261,725,593.27 in the same period last year[7] - Net profit attributable to shareholders was -¥20,362,903.27, representing a decline of 181.09% from ¥25,111,969.86 year-over-year[7] - Basic and diluted earnings per share were both -¥0.0253, down 181.09% from ¥0.0312 in the same period last year[7] - The company reported a net loss of CNY 827,377,017.61, compared to a loss of CNY 821,453,520.71 in the previous period[59] - Operating profit turned negative at -¥22,668,128.94, down from ¥26,105,025.34 in the prior year[62] - The total comprehensive income for the period was -¥20,481,225.29, a significant decline from ¥21,426,835.02 in the previous year[63] Cash Flow and Liquidity - The net cash flow from operating activities was ¥19,060,850.33, a significant improvement from -¥60,452,396.95 in the previous year[7] - Cash and cash equivalents at the end of the period decreased by 30.16% compared to the beginning of the year, primarily due to repayment of bank loans[17] - Cash flow from financing activities resulted in a net outflow of ¥76,842,158.98, compared to a net inflow of ¥37,690,655.32 in the previous period[71] - The ending balance of cash and cash equivalents was ¥121,261,056.80, down 62.9% from ¥326,300,551.89 in the previous period[71] - Total cash outflow from operating activities was ¥252,560,246.94, a decrease of 34.4% from ¥385,528,154.20 in the previous period[70] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,831,566,761.61, a decrease of 7.28% from ¥1,975,326,108.82 at the end of the previous year[7] - Current liabilities decreased from CNY 394,901,241.27 to CNY 273,057,384.56, a reduction of about 30.8%[53] - Non-current liabilities decreased from CNY 22,547,636.01 to CNY 18,763,088.48, a decrease of approximately 16.5%[53] - Total equity decreased from CNY 1,601,206,685.19 to CNY 1,580,781,959.89, a decline of about 1.3%[54] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 47,406[10] - The top shareholder, Jin Daoming, held 10.84% of shares, amounting to 87,138,800 shares, which are currently pledged[10] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[11] Government Support and Subsidies - The company received government subsidies amounting to ¥1,058,078.34 during the reporting period[8] Investment and Capital Management - The total amount of raised funds is CNY 44,800 million, with CNY 258.45 million invested in the current quarter[42] - Cumulative investment of raised funds amounts to CNY 41,664.74 million, representing 93% of the total raised funds[43] - The company plans to adopt a prudent investment strategy, focusing on high-quality investment targets that complement its business[38] Operational Strategies - The company plans to intensify product promotion efforts and strictly control expenses to mitigate revenue decline in Q2 2019[34] - The company aims to enhance product and technology innovation and strengthen brand promotion to improve market competitiveness[36] - The company plans to strengthen management of subsidiaries and enhance internal control systems to mitigate management risks associated with expansion[38] Research and Development - The company reported a decrease in research and development expenses to ¥6,468,879.43 from ¥7,810,496.93, a reduction of approximately 17.1%[60]

Financial Performance - Operating revenue for the reporting period was CNY 215,155,627.19, down 30.34% year-on-year, with a year-to-date total of CNY 723,351,740.70, a decrease of 4.43%[7] - Net profit attributable to shareholders was CNY 14,429,464.39, a decline of 8.27% compared to the same period last year, with a year-to-date total of CNY 45,490,852.41, down 9.36%[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 8,891,351.67, a decrease of 37.11% year-on-year[7] - The basic earnings per share for the reporting period was CNY 0.0179, down 8.21% compared to the same period last year[7] - The weighted average return on equity was 0.59%, a decrease of 0.08% compared to the previous year[7] - Total operating revenue for the third quarter was CNY 215,155,627.19, a decrease from CNY 308,876,812.69 in the previous period[40] - Total operating costs amounted to CNY 209,089,339.10, down from CNY 291,708,757.61 year-over-year[40] - Net profit for the period was CNY 14,285,471.47, slightly down from CNY 14,673,470.33 in the same period last year[42] - The company reported a total comprehensive income of CNY 18,881,796.44, compared to CNY 21,304,396.29 in the previous year[43] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,946,079,402.13, a decrease of 4.02% compared to the end of the previous year[7] - Total assets decreased from CNY 3,069,523,158.22 at the beginning of the period to CNY 2,946,079,402.13 by the end of the period, a decline of approximately 4.01%[32] - Current assets decreased from CNY 1,305,778,038.37 to CNY 1,159,521,260.29, representing a reduction of about 11.21%[33] - Total liabilities decreased from CNY 612,238,862.53 to CNY 462,131,802.52, a reduction of about 24.5%[35] - Current liabilities decreased from CNY 569,331,454.27 to CNY 435,170,569.61, a decline of approximately 23.5%[35] - Non-current liabilities decreased from CNY 42,907,408.26 to CNY 26,961,232.91, a reduction of about 37.2%[35] - Total equity increased from CNY 2,457,284,295.69 to CNY 2,483,947,599.61, an increase of approximately 1.09%[35] Cash Flow - The net cash flow from operating activities was CNY -56,710,951.59, representing a significant decline of 4,188.47% year-on-year[7] - The company did not receive any investment cash during the reporting period, resulting in a 100% decrease in cash flow from financing activities[20] - Cash and cash equivalents decreased by 63.27% compared to the beginning of the year, mainly due to the purchase of financial products and operational payments[18] - The net cash flow from investment activities was -¥92,682,564.06, compared to -¥35,620,927.54 in the previous period, indicating a significant increase in cash outflow[57] - The net cash flow from financing activities was -¥59,689,319.51, slightly worse than -¥58,464,852.89 from the previous period[57] - The total cash and cash equivalents at the end of the period decreased to ¥119,321,927.39 from ¥284,737,618.14 in the previous period[58] - Operating cash inflow totaled ¥108,043,311.51, down from ¥183,207,155.03 in the previous period, reflecting a decline in operational performance[59] - The net cash flow from operating activities was -¥12,603,212.99, a significant drop from a positive cash flow of ¥6,825,292.58 in the previous period[59] - Cash received from sales of goods and services was ¥65,180,015.58, down from ¥115,760,411.22 in the previous period, indicating reduced sales performance[59] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 51,860[11] - The largest shareholder, Jin Daoming, held 10.83% of the shares, amounting to 87,138,800 shares, with a portion pledged[11] - The company transferred a total of 40.8 million shares (5.07% of total shares) to Rongjie Group at a price of RMB 7.0 per share, totaling RMB 285.6 million[23] - The actual controller of the company changed to Rongjie Group after the share transfer[23] Investment and R&D - The company reported a government subsidy of CNY 10,405,308.32 during the year[8] - Research and development expenses increased to CNY 14,774,467.47, up from CNY 9,223,286.70 year-over-year, indicating a focus on innovation[40] - Investment income increased by 45.02% compared to the same period last year, mainly due to increased investment income from joint ventures and associates[19] - The company achieved an investment income of CNY 3,872,463.67, compared to CNY 1,289,178.93 in the previous period, reflecting improved performance in joint ventures[42] - The company reported a significant increase in investment income from joint ventures, rising to ¥11,943,735.71 from ¥2,110,349.74, an increase of approximately 466.5%[54]

Financial Performance - Total revenue for the first half of 2018 was CNY 508,196,113.51, representing a 13.43% increase compared to CNY 448,034,697.92 in the same period last year[16]. - Net profit attributable to shareholders decreased by 9.86% to CNY 31,061,388.02 from CNY 34,460,706.70 year-on-year[16]. - Net profit after deducting non-recurring gains and losses fell by 19.64% to CNY 26,892,919.56 compared to CNY 33,466,406.10 in the previous year[16]. - The total profit amounted to CNY 33,848,942.72, a decrease of 17.88% compared to the previous year[23]. - The company achieved operating revenue of CNY 508,196,113.51, representing a year-on-year growth of 13.43%[23]. - Basic and diluted earnings per share decreased by 10.02% to CNY 0.0386 from CNY 0.0429 year-on-year[16]. - The company reported a net profit of 29,534,541.61 CNY, a decrease of 13.38% from 34,099,173.23 CNY in the previous year[136]. - The company reported a total comprehensive income of 5,927,941 CNY during the period[156]. Cash Flow and Assets - The net cash flow from operating activities was negative at CNY -79,485,068.61, a decline of 204.80% from CNY 75,848,000.54 in the same period last year[16]. - As of the end of the reporting period, cash and cash equivalents amounted to ¥247.67 million, representing 8.33% of total assets, a decrease of 7.44% compared to the previous year[46]. - The company's total assets at the end of the reporting period were ¥2,564,902,280.51, down from ¥2,598,482,217.37 at the beginning of the year[133]. - The company's current assets totaled CNY 1,197,213,445.56, down from CNY 1,305,778,038.37, indicating a decrease of about 8.3%[127]. - The total liabilities decreased from CNY 612,238,862.53 to CNY 507,791,047.40, a reduction of about 17.0%[128]. - The total equity remained stable at CNY 2,464,811,465.66, with no change in the share capital of CNY 804,542,313.00[128]. Investments and R&D - The company increased R&D investment by 38.75% to ¥27,690,545.03, driven by subsidiaries' efforts[39]. - The company aims to leverage favorable policies in the health industry to boost product sales and enhance market competitiveness[29]. - The company is committed to continuous innovation and has formed a strong brand presence in the health sector, ensuring a competitive edge in the market[30]. - The company established a universal super donor iPSC cell resource bank, which can serve approximately 36 million people in China[36]. - The company is actively promoting clinical research for stem cells to treat immune diseases and osteoarthritis[36]. Market Position and Strategy - The company is positioned as a leader in the health industry, focusing on a comprehensive health service system that integrates health products, health testing, and health management[26]. - The market for health services in China is projected to exceed CNY 8 trillion by 2020 and reach CNY 16 trillion by 2030, driven by an aging population and increasing health awareness[24]. - The company has developed a diverse range of products, including far-infrared therapy products, massage chairs, and small massage devices, enhancing its market presence[28]. - The company has established a robust marketing channel combining distribution, retail, and e-commerce, creating a comprehensive family health service system[23]. Shareholder Information - The company plans not to distribute cash dividends or issue bonus shares[5]. - The company’s total share capital is 804,542,313 shares, with 69.99% being unrestricted shares[106]. - The largest shareholder, Jin Daoming, holds 14.44% of the shares, totaling 116,178,800 shares[111]. - The total number of ordinary shareholders at the end of the reporting period was 55,013[111]. - Rongjie Investment Holding Group increased its stake in the company by acquiring 45,512,302 shares, representing 5.66% of total shares, bringing its total ownership to 10.73%[101]. Risks and Challenges - The company is facing market risks due to a complex domestic economic environment and is actively adjusting its market strategies and increasing new product R&D[75]. - The company is experiencing negative impacts on its performance due to significant depreciation pressure on the RMB against the USD and EUR, and is taking measures to mitigate exchange rate risks[77]. - The company is addressing management risks associated with its expanding scale by innovating management mechanisms and establishing a management system that aligns with its growth[76]. Corporate Governance - The company experienced changes in its board members, with two directors resigning on May 15, 2018, due to personal reasons[119]. - The company has implemented a stock incentive plan to enhance the motivation of management and core employees, aligning their interests with those of shareholders[88]. - The report indicates that there were no changes in the controlling shareholder or actual controller during the reporting period[113]. Financial Reporting and Compliance - The financial report for the first half of 2018 was not audited, indicating a potential area of concern for investors[124]. - The company adheres to the accounting standards and principles, ensuring the financial statements accurately reflect its financial position and operating results[174]. - The company prepares consolidated financial statements based on its own and subsidiaries' financial reports, reflecting the overall financial position, operating results, and cash flows of the entire corporate group[181].

Financial Performance - Total revenue for Q1 2018 was CNY 261,725,593.27, an increase of 17.15% compared to CNY 223,411,294.83 in the same period last year[7] - Net profit attributable to shareholders was CNY 25,111,969.86, representing a growth of 52.90% from CNY 16,424,318.46 year-on-year[7] - Net profit excluding non-recurring gains and losses reached CNY 22,689,736.19, up 57.21% from CNY 14,432,479.84 in the previous year[7] - Basic earnings per share increased by 48.57% to CNY 0.0312 from CNY 0.0210 in the same period last year[7] - The company's total revenue for Q1 2018 was ¥261,725,593.27, representing a year-on-year growth of 17.15%[23] - Net profit attributable to ordinary shareholders for the same period was ¥25,111,969.86, showing a year-on-year increase of 52.90%[23] - The company reported a significant increase in investment income, reaching CNY 3,648,224.54 in Q1 2018, compared to CNY 85,280.29 in Q1 2017[48] - The total comprehensive income for Q1 2018 was CNY 21,630,272.49, compared to CNY 16,490,218.48 in the same period last year[48] Cash Flow and Financial Position - The company reported a net cash flow from operating activities of -CNY 60,452,396.95, worsening from -CNY 21,663,694.35 in the previous year[7] - Cash and cash equivalents at the end of Q1 2018 were CNY 257,479,142.27, up from CNY 243,090,877.48[40] - The company's cash and cash equivalents at the end of the reporting period amounted to CNY 327,636,709.24, slightly up from CNY 326,322,604.49 at the beginning of the period[36] - The net cash flow from operating activities for the current period is CNY 3,990,209.53, a decrease of 40.5% compared to CNY 6,713,265.52 in the previous period[56] - Total cash inflow from operating activities is CNY 51,321,472.28, while cash outflow is CNY 47,331,262.75, resulting in a net cash flow of CNY 3,990,209.53[56] - Cash inflow from financing activities increased to CNY 60,000,000.00, up from CNY 30,000,000.00 in the previous period, marking a 100% increase[57] - The total cash and cash equivalents at the end of the period is CNY 256,636,442.87, a decrease from CNY 285,745,264.72 in the previous period[57] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 59,357[13] - The company reported a total of 241,467,987 shares with 14,078,404 shares released from restrictions during the period[16] - The number of shares held by the top 10 unrestricted shareholders includes 29,044,700 shares held by Jin Daoming, representing 3.12% of total shares[14] - The company has not conducted any repurchase agreements among the top 10 shareholders during the reporting period[14] - The company plans to release 80,000 shares from the equity incentive plan for Gong Xiangmin on August 27, 2018[16] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,054,414,800.31, a decrease of 0.49% from CNY 3,069,523,158.22 at the end of the previous year[7] - The total assets as of the end of Q1 2018 were CNY 2,631,425,460.65, compared to CNY 2,598,482,217.37 at the beginning of the period[42] - The total liabilities decreased to CNY 380,790,735.10 from CNY 353,949,712.40 in the previous period[42] - The company's equity attributable to shareholders increased to CNY 2,250,634,725.55 from CNY 2,244,532,504.97[42] Operational Efficiency - The company has focused on market development and promotion of existing products, leading to steady revenue growth[23] - The company has effectively controlled management expenses through streamlined processes[23] - Operating costs amounted to CNY 239,403,800.15, compared to CNY 208,404,243.70 in the prior period[44] - The gross profit margin improved to 38.1% in Q1 2018, compared to 34.5% in Q1 2017, indicating better cost management[48] Strategic Initiatives - The company plans to enhance product and technology innovation while expanding its marketing network to mitigate market risks[9] - The company is focusing on strategic investments and mergers to achieve resource sharing and enhance profitability[10]

Financial Performance - The company's operating revenue for 2017 was CNY 1,217,589,896.35, representing a 102.96% increase compared to CNY 599,904,977.70 in 2016[16] - The net profit attributable to shareholders decreased by 20.60% to CNY 67,995,067.28 from CNY 85,634,524.09 in the previous year[16] - The net profit after deducting non-recurring gains and losses increased by 27.48% to CNY 86,675,408.10 from CNY 67,990,774.69 in 2016[16] - The total profit for the period was CNY 81,852,812.95, a decrease of 17.33% compared to the previous year[26] - The net profit attributable to shareholders was CNY 67,995,067.28, down 20.60% year-on-year[42] - The basic earnings per share decreased by 33.33% to CNY 0.08 from CNY 0.12 in 2016[16] - The weighted average return on equity was 2.91%, down from 5.47% in the previous year[16] Assets and Liabilities - The company's total assets at the end of 2017 were CNY 3,069,523,158.22, a 7.37% increase from CNY 2,858,739,052.15 in 2016[16] - The net assets attributable to shareholders increased by 4.68% to CNY 2,436,168,897.68 from CNY 2,327,244,577.60 in 2016[16] - The total assets at the end of 2017 included cash and cash equivalents of ¥326,322,604.49, down from ¥377,037,093.14 in 2016[71] - Accounts receivable increased significantly to ¥531,777,786.77, representing 17.32% of total assets, up from 9.78% in 2016[71] Cash Flow - The net cash flow from operating activities was negative CNY 86,377,856.21, a decrease of 296.58% compared to CNY 43,940,565.56 in 2016[16] - Operating cash inflow increased by 89.46% to ¥1,163,622,332.81 in 2017, while cash outflow rose by 119.20% to ¥1,250,000,189.02[67] - The net increase in cash and cash equivalents was -¥52,050,646.00, a significant decline of 188.73% compared to the previous year[68] Dividends and Profit Distribution - The company plans to distribute a cash dividend of CNY 0.30 per 10 shares to all shareholders[4] - The company declared a cash dividend of RMB 0.30 per 10 shares, totaling RMB 24,136,269.39 for the year 2017[111] - The total distributable profit available for shareholders as of December 31, 2017, was RMB 296,106,059.98, with cash dividends accounting for 100% of the profit distribution[114] - The net profit attributable to the parent company for 2017 was RMB 67,995,067.28, representing a cash dividend payout ratio of 35.50%[116] Strategic Focus and Market Position - The company is focusing on expanding its health management services, including health testing and remote medical management[26] - The company is positioned as a leader in the health industry, with a strategic focus on health products, health food, health testing, and health management[26] - The company aims to integrate health products, health testing, and health management into a comprehensive family health service system[31] - The health service industry in China is projected to exceed CNY 8 trillion by 2020 and reach CNY 16 trillion by 2030, indicating significant market potential[32] Research and Development - The company’s R&D expenditure for 2017 was ¥52,241,309.65, representing 4.29% of total revenue, an increase of ¥21,756,066.47 from the previous year[65] - The company will increase investment in research and development to improve product quality and innovate new products, collaborating with universities and research institutions[103] - Research and development investments are set to increase by 30%, focusing on advanced health monitoring technologies[125] Subsidiaries and Acquisitions - The company established three new subsidiaries in 2017, expanding its operational footprint[60] - The company acquired a 21% stake in Beijing Central Broadcasting United Media Investment Co., Ltd. for CNY 200,000,000.00, enhancing its health industry chain[36] - The company made a significant equity investment of CNY 6.5 million in Anhui Lejin Health Management Co., acquiring a 51% stake, with an expected return of CNY 18 million[76] Risks and Challenges - The company has outlined potential risks and countermeasures in its future development outlook section[4] - The company faces market risks due to a complex economic environment and will adjust marketing strategies to mitigate these risks[104] - The company recognizes the risk of core personnel turnover and will implement measures such as stock incentive plans to retain key talent[106] Shareholder Management - The company has a legal obligation to distribute at least 20% of its profits as cash dividends during periods of profitability[111] - The company has not proposed any ordinary share cash dividend distribution plans for the reporting period despite having positive distributable profits[116] - The company is actively managing its shareholder agreements to align interests and mitigate conflicts[123] Corporate Governance - The company has maintained compliance with laws and regulations, ensuring accurate and timely information disclosure to shareholders[175] - The company is committed to social responsibility, contributing to local economic development and participating in social welfare activities[175] - The company has established a clear framework for performance compensation in case of unmet profit targets[122]

Financial Performance - Operating revenue for the reporting period was ¥308,876,812.69, representing a significant increase of 155.62% year-on-year[7]. - Net profit attributable to shareholders was ¥15,730,220.79, a decrease of 10.93% compared to the same period last year[7]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥14,137,955.57, an increase of 33.75% year-on-year[7]. - Basic earnings per share for the reporting period was ¥0.0195, down 20.41% compared to the same period last year[7]. - The weighted average return on net assets was 0.67%, a decrease of 44.17% compared to the same period last year[7]. - Total operating revenue for the third quarter reached CNY 308,876,812.69, a significant increase from CNY 120,834,945.72 in the previous period[34]. - Net profit for the quarter was CNY 14,673,470.33, down from CNY 17,093,284.15 year-over-year[35]. - The net profit attributable to the parent company was CNY 15,730,220.79, compared to CNY 17,661,137.57 in the previous year[35]. - Basic and diluted earnings per share were both CNY 0.0195, compared to CNY 0.0245 in the same period last year[36]. - Net profit attributable to the parent company was ¥50,190,927.49, up from ¥32,987,943.62 in the previous period, reflecting a growth of approximately 52.2%[43]. - Total comprehensive income for the current period was ¥56,395,130.02, compared to ¥37,370,082.99 in the previous period, an increase of approximately 51.1%[44]. Assets and Liabilities - Total assets at the end of the reporting period reached ¥2,929,728,399.43, an increase of 2.48% compared to the end of the previous year[7]. - Total liabilities rose from ¥512,385,500.75 to ¥555,232,333.98, an increase of approximately 8.3%[28]. - The company's equity attributable to shareholders increased from ¥2,327,244,577.60 to ¥2,362,836,765.14, a growth of about 1.5%[29]. - The company's short-term borrowings decreased from ¥171,036,592.09 to ¥162,813,440.81, a reduction of about 7.1%[28]. - The company reported a total asset value of CNY 2,487,217,100.55, slightly down from CNY 2,499,944,120.04 at the end of the previous period[32]. - Total liabilities were CNY 294,166,636.02, a marginal increase from CNY 290,261,859.14[32]. - The company's equity totaled CNY 2,193,050,464.53, down from CNY 2,209,682,260.90 in the previous period[32]. Cash Flow - The company reported a net cash flow from operating activities of ¥1,387,094.41, which represents a decline of 103.12% year-on-year[7]. - The cash inflow from operating activities totaled CNY 983,711,854.38, compared to CNY 355,537,342.32 in the previous period, representing an increase of approximately 176%[50]. - The net cash flow from operating activities was CNY 1,387,094.41, a significant improvement from a net outflow of CNY 44,455,878.99 in the same period last year[50]. - The cash outflow from investing activities was CNY 51,620,698.12, compared to CNY 146,412,494.53 in the previous period, indicating a decrease of about 65%[51]. - The net cash flow from financing activities was negative at CNY -58,464,852.89, compared to CNY -8,687,325.32 in the previous period, reflecting a worsening situation[51]. - The total cash and cash equivalents at the end of the period stood at CNY 284,737,618.14, down from CNY 251,777,464.43 in the previous period[52]. - The company experienced a net decrease in cash and cash equivalents of CNY -92,299,475.00, compared to a decrease of CNY -66,599,359.78 in the previous period[51]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 58,315[11]. - The top ten shareholders held a combined 49.09% of the company's shares, with the largest shareholder holding 14.44%[11]. - The total number of shares subject to lock-up restrictions is 314,487,011, with 10,506,000 shares currently under lock-up[17]. - The company has a total of 87,134,100 shares held by executives, with a 25% annual release of lock-up during their tenure[15]. - The company plans to partially lift lock-up restrictions on several executives' shares on December 5, 2017, including 14,000,000 shares held by Chen Wei[15]. - The report indicates that 6,396,400 shares are subject to lock-up due to equity incentives and management restrictions[17]. - The company has a total of 19,140,000 shares held by executive Ma Shao Qin, with a 25% annual release of lock-up during their tenure[15]. - The company has a total of 4,140,000 shares held by executive Wang Yan, with a 25% annual release of lock-up during their tenure[15]. - The report indicates that 3,888,889 shares held by Huang Xiaoxia are subject to lock-up restrictions, with a partial release scheduled for December 5, 2017[15]. - The report highlights that 9,650,053 shares are held by Anhui Wantou Industrial Investment Co., Ltd., which will also see a release of lock-up on December 5, 2017[17]. Operational Metrics - Operating costs amounted to CNY 291,708,757.61, compared to CNY 112,471,612.70 in the same period last year[34]. - The company's cash and cash equivalents decreased from ¥377,037,093.14 to ¥284,737,618.14, a decline of approximately 24.6%[26]. - Accounts receivable increased significantly from ¥279,444,775.47 to ¥396,024,595.24, representing a growth of about 41.9%[26]. - Inventory rose from ¥261,134,244.41 to ¥315,463,607.62, marking an increase of approximately 20.8%[26]. - The company's other receivables increased from ¥208,276,076.61 to ¥236,524,676.96, representing a growth of approximately 13.5%[26]. - The company's retained earnings increased from ¥252,251,499.14 to ¥278,301,920.19, reflecting a growth of about 10.3%[29]. - The total operating costs for the current period were ¥710,017,912.80, up from ¥308,966,747.43, which is an increase of about 130.0%[41]. - Investment income decreased to ¥9,877,687.93 from ¥14,735,201.51, a decline of approximately 32.0%[43]. - Tax expenses for the current period were ¥11,147,996.94, compared to ¥4,691,075.06 in the previous period, representing an increase of about 137.5%[43]. Future Outlook - Future outlook includes potential market expansion and new product development, although specific details were not provided in the current report[44].

Financial Performance - Total revenue for the first half of 2017 reached ¥448,034,697.92, representing a 125.76% increase compared to ¥198,456,861.68 in the same period last year[18]. - Net profit attributable to shareholders was ¥34,460,706.70, up 124.84% from ¥15,326,806.05 year-on-year[18]. - Net profit after deducting non-recurring gains and losses was ¥33,466,406.10, a significant increase of 214.93% compared to ¥10,626,722.37 in the previous year[18]. - Basic earnings per share rose to ¥0.0429, reflecting a 101.41% increase from ¥0.0213 in the same period last year[18]. - The total profit reached CNY 41,218,072.87, an increase of 128.24% compared to the previous year[25]. - The company achieved operating revenue of CNY 448,034,697.92, representing a year-on-year growth of 125.76%[25]. - The company reported a gross profit margin of approximately 6.5% for the first half of 2017, compared to 0.8% in the same period of 2016[145]. - The company achieved an operating profit of CNY 40,085,143.26, compared to CNY 13,305,488.72 in the previous year, representing an increase of approximately 201.5%[145]. Cash Flow and Assets - The net cash flow from operating activities was ¥75,848,000.54, a turnaround from a negative cash flow of ¥24,763,554.22 in the previous year[18]. - The company’s cash and cash equivalents increased to ¥454,899,314.51, up from ¥248,869,815.02, representing a 2.64% increase in total asset proportion[53]. - The total cash inflow from operating activities was CNY 740,825,852.51, an increase from CNY 243,834,382.99 in the previous period[152]. - Cash received from sales of goods and services amounted to CNY 492,978,902.89, compared to CNY 231,109,307.85 previously[151]. - The ending cash and cash equivalents balance was CNY 454,899,314.51, up from CNY 248,869,815.02 in the previous period[153]. - Total assets at the end of the reporting period were ¥2,884,312,268.88, a slight increase of 0.89% from ¥2,858,739,052.15 at the end of the previous year[18]. Market Position and Strategy - The company is focusing on the health industry, particularly in health products manufacturing, online sales, and community service experiences[26]. - The health industry is projected to exceed CNY 10 trillion in market size during the "13th Five-Year Plan" period, with a government target to increase the medical service market from CNY 2 trillion to CNY 8 trillion[28]. - The company is positioned as a leading player in the health industry, with a strong market share and rapid growth in revenue and profit[31]. - The company aims to create a closed-loop health solution system for families, integrating health products, health testing, and health management[31]. - Future market potential is significant due to increasing consumer demand for health services and solutions, driven by an aging population and rising health awareness[30]. - The company plans to leverage capital market advantages to enhance its health industry chain through mergers and acquisitions[26]. Subsidiaries and Investments - The company has established multiple subsidiaries, including Saunalux GmbH in Germany and Wuhu Sang Le Jin Electronic Technology Co., Ltd. in Anhui, with ownership stakes of 100% and 94% respectively[74]. - The company reported that its subsidiary, Anhui Jiugong Health Industry Co., Ltd., generated a revenue of 104.37 million CNY and a net profit of 15.13 million CNY[72]. - The subsidiary Shenzhen Furuisi Health Equipment Co., Ltd. achieved a revenue of 141.78 million CNY and a net profit of 13.62 million CNY[72]. - The company has formed a diversified product structure covering health therapy, environment, and wellness, enhancing overall competitiveness[36]. Shareholder and Equity Information - The company will not distribute cash dividends or issue bonus shares for the half-year period[81]. - The total number of shares held by the top ten shareholders includes significant stakes from Jin Daoming and Han Daohu, indicating concentrated ownership[118]. - The total number of shares before the change was 804,698,300, with a breakdown of 41.46% being restricted shares and 58.54% being unrestricted shares[112]. - The company granted 19.8 million restricted stocks at a price of 6.79 CNY per share, adjusting from an initial 23.5 million due to some participants opting out[88]. - The total number of shareholders at the end of the reporting period was 59,535[118]. Challenges and Future Outlook - The company is currently in a critical adjustment and transformation phase, facing significant market risks due to the complex domestic economic environment[75]. - The company plans to enhance its marketing strategies and invest in new product development to mitigate adverse external market factors[76]. - The company is focusing on mergers and acquisitions to achieve resource sharing and complementary advantages, while also facing challenges related to team stability and new business areas[77]. - The company did not provide specific guidance for future performance or market expansion plans in the current report[158]. Compliance and Governance - The half-year financial report has not been audited, indicating a lack of external validation for the reported figures[83]. - The company has not engaged in any major asset or equity sales during the reporting period[70]. - There are no significant legal disputes or penalties reported during the period[86][87]. - The company has not engaged in any significant related party transactions during the reporting period[94].

Financial Performance - Total revenue for Q1 2017 reached ¥223,411,294.83, representing a 114.40% increase compared to ¥104,202,215.82 in the same period last year[7] - Net profit attributable to shareholders was ¥16,424,318.46, up 99.62% from ¥8,227,973.44 year-on-year[7] - Net profit excluding non-recurring gains and losses was ¥14,432,479.84, reflecting a 77.80% increase from ¥8,117,169.99 in the previous year[7] - The company's operating revenue for Q1 2017 reached ¥223,411,294.83, representing a year-on-year increase of 114.40% due to the consolidation of revenues from newly acquired subsidiaries Ruiyu Fitness and Furuisi[24] - The company reported a 52.05% decrease in investment income year-on-year, primarily due to reduced returns from financial product investments[22] - The total profit for Q1 2017 reached CNY 20,068,035.38, up from CNY 9,857,093.32 in the previous year, indicating a growth of 103.3%[51] - The total comprehensive income for Q1 2017 was CNY 16,934,788.96, compared to CNY 9,587,271.53 in the same period last year, marking an increase of 76.8%[52] Cash Flow and Liquidity - The company reported a negative net cash flow from operating activities of ¥21,663,694.35, compared to a negative cash flow of ¥19,793,277.98 in the same period last year[7] - The cash inflow from operating activities was CNY 289,412,415.74, significantly higher than CNY 118,632,832.99 in the previous period[58] - The net cash flow from investment activities was 25,768,561.56 CNY, compared to 21,227,781.32 CNY in the previous period, showing a positive trend in investment returns[59] - The total cash and cash equivalents at the end of the period increased to 381,676,580.91 CNY from 309,628,663.69 CNY, indicating a positive liquidity position[60] - The net increase in cash and cash equivalents for the period was 4,639,487.77 CNY, contrasting with a decrease of -8,748,160.52 CNY in the previous period, indicating a recovery in cash flow[60] Shareholder Information - The top shareholder, Jin Daoming, holds 14.44% of the shares, with 87,134,100 shares pledged[12] - The total number of restricted shares for major shareholders includes 10,240,000 shares held by Gong Xiangmin, with no shares released during the current period[15] - Chen Mengyang holds 4,200,000 restricted shares, all of which remain restricted as of the end of the period[16] - Han Daohu holds 58,158,000 restricted shares, with no shares released during the current period[16] - The total number of restricted shares for Ma Shaoqin is 25,089,400, with 5,949,400 shares released during the current period, leaving 19,140,000 shares still restricted[16] Operational Costs and Expenses - The company's operating costs increased by 149.42% year-on-year, primarily attributed to the consolidation of the newly acquired subsidiaries[22] - The company's financial expenses rose by 128.65% compared to the previous year, mainly due to the consolidation of new subsidiaries[22] - The company's tax expenses increased by 116.11% year-on-year, largely due to the consolidation of new subsidiaries[23] - The company's sales expenses decreased to CNY 17,317,654.68 from CNY 11,028,729.05, reflecting a reduction of 28.5%[51] - The management expenses increased to CNY 29,569,712.86 from CNY 22,966,330.91, showing an increase of 28.7%[51] Strategic Initiatives - The company is actively adjusting market strategies and exploring new marketing models to mitigate market risks due to economic uncertainties[9] - The company plans to enhance product and technology innovation while increasing brand and product promotion efforts[9] - The company is focusing on enhancing its core competitiveness and market share through product upgrades and new product development[26] - The company is expanding its online and offline sales channels for health products[26] - The company is committed to strengthening its brand influence through marketing activities[26] Investment and Projects - The company has invested ¥95,650.98 million in total fundraising, with ¥84,100.15 million already utilized[31] - The infrared sauna room production project has reached an investment progress of 102.05%[31] - The regional marketing center construction project has achieved a completion rate of 95.06%[31] - The total investment for the acquisition of Saunalux was EUR 6.35 million, equivalent to RMB 53.216 million, with actual funds used amounting to RMB 53.216 million[32] - The total investment for the R&D center project is estimated at CNY 59.67 million, with CNY 55 million planned to be funded from the raised funds[33]